Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

Phase 3 Completed 916 enrolled Novartis Vaccines

RandomizedParallel-groupSingle-blindPrevention

Summary

This study will investigate safety and immunogenicity of a monovalent conjugated vaccine against Haemophilus influenzae type b in healthy children aged 2 to 4 months in China.

Timeline

Start: 2008-11
Primary completion: 2009-02
Completion: 2009-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Haemophilus influenzae type b vaccine	Vaccine	—	Intramuscular

Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

Summary

Timeline

Drugs

Indications